ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,266.02
-0.75%
Dow Jones
38,455.93
-1.02%
US Dollar vs MXN
16.92762
0.78%
Brent Oil
83.18
-1.36%
Bitcoin
67,277.68
-1.48%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Selecta Biosciences Inc (SELB)

  7. Selecta Biosciences Inc (SELB) Noticias

SELB

Selecta Biosciences (SELB)

Selecta Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SELB
FechaHoraFuenteTítuloSímboloCompañía
22/05/202406:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
08/05/202406:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SELBSelecta Biosciences Inc
26/04/202408:09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SELBSelecta Biosciences Inc
26/04/202406:57Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SELBSelecta Biosciences Inc
19/04/202415:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
10/04/202420:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
10/04/202415:29Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SELBSelecta Biosciences Inc
07/03/202406:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SELBSelecta Biosciences Inc
14/02/202411:38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SELBSelecta Biosciences Inc
31/01/202415:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SELBSelecta Biosciences Inc
23/01/202415:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SELBSelecta Biosciences Inc
12/01/202415:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SELBSelecta Biosciences Inc
08/01/202406:10GlobeNewswire Inc.Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for AutoimmunityNASDAQ:SELBSelecta Biosciences Inc
08/01/202406:00GlobeNewswire Inc.Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia GravisNASDAQ:SELBSelecta Biosciences Inc
08/12/202315:28Edgar (US Regulatory)Form 8-A12G - Registration of securities [Section 12(g)]NASDAQ:SELBSelecta Biosciences Inc
04/12/202315:39Edgar (US Regulatory)Form D/A - Notice of Exempt Offering of Securities: [Amend]NASDAQ:SELBSelecta Biosciences Inc
03/12/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SELBSelecta Biosciences Inc
01/12/202315:43Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SELBSelecta Biosciences Inc
01/12/202307:31Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:SELBSelecta Biosciences Inc
22/11/202315:39Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:SELBSelecta Biosciences Inc
13/11/202307:05GlobeNewswire Inc.Selecta Biosciences Announces Merger with Cartesian TherapeuticsNASDAQ:SELBSelecta Biosciences Inc
31/10/202315:03GlobeNewswire Inc.Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner SobiNASDAQ:SELBSelecta Biosciences Inc
25/10/202316:29Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SELBSelecta Biosciences Inc
17/08/202306:00GlobeNewswire Inc.Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 EconomicsNASDAQ:SELBSelecta Biosciences Inc
14/08/202306:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SELBSelecta Biosciences Inc
16/06/202315:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SELBSelecta Biosciences Inc
13/06/202309:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SELBSelecta Biosciences Inc
12/06/202315:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SELBSelecta Biosciences Inc
31/05/202306:00GlobeNewswire Inc.Selecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of RheumatologyNASDAQ:SELBSelecta Biosciences Inc
04/05/202306:37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SELBSelecta Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SELB

Su Consulta Reciente

ASX
AEVRA
GATE
WEXUSDT
WaultSwap
LSE
BO57
State Is.27
ASX
CTXKOC
USOTC
HYSR
SunHydrogen (QB)
AMEX
UBN
BIT
GS0258
Goldman Sachs
BIT
I06846
Intesa Sanpaolo
BOV
VALEM59
VALEM59 Ex:53,08
BITMOT
855980
Eib Tf 1,75% Mz25 Nok
NASDAQ
JSJWX
Stable Value Portfolio C...
NASDAQ
ACTQZX
Advisors Corporate Trust...
TSXV
TBIX
Trustbix
BIT
P1ME77
BNP Paribas Issuance
ASX
TPE
ASX
IXC
Invex Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados